NYSE$PBH
Prestige Consumer Healthcare Inc · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
PBH Q3 2024 — $283K revenue, 49.00 EPS
The extent to which these conditions impact our results and liquidity will depend on future developments, which are highly uncertain and cannot be predicte. Prestige Consumer Healthcare Inc reported Q3 2024 results. Diluted EPS came in at $49.00. Net income of $160K. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $283K.
- Diluted EPS: $49.00.
- Net income: $160K.
- Operating income: $87K.
- Gross profit: $158K.
Headline financials
Revenue & EPS history
Prestige Consumer · Revenue · Quarterly
$283M
Revenue by segment
Prestige Consumer · $286M total across 2 segments · Q2 2024
- North American OTC Healthcare$244M-3.0%85.4%
- International OTC Healthcare$41.9M+12.6%14.6%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2024
+1.3%
Avg return
Earnings day
+1.4%
Avg return
5 days after
+1.3%
Avg return
30 days after
55%
35 / 64 earnings
Positive
+25.7%
Q4 2018
Best reaction
-14.3%
Q3 2018
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | +1.5% | -7.4% | -4.9% | |
| Q3 2026 | -2.2% | -1.4% | +0.2% | |
| Q2 2026 | +2.2% | +1.3% | +1.7% | |
| Q4 2025 | +7.0% | +6.8% | +4.5% | |
| Q3 2025 | +14.8% | +13.0% | +17.0% | |
| Q2 2025 | +3.5% | +5.1% | +8.6% | |
| Q1 2025 | -2.4% | -0.9% | +9.5% | |
| Q4 2024 | -5.7% | -8.3% | -8.0% | |
| Q3 2024 | +9.2% | +5.8% | +17.2% | |
| Q2 2024 | +0.1% | +0.6% | -1.5% | |
| Q1 2024 | +2.2% | -2.5% | -11.4% | |
| Q4 2023 | -0.8% | -4.7% | -4.5% | |
| Q3 2023 | -7.9% | -8.3% | -8.9% | |
| Q2 2023 | +2.2% | +4.6% | +17.7% | |
| Q1 2023 | -0.3% | -3.9% | -15.2% | |
| Q4 2022 | -0.8% | +4.0% | +1.6% | |
| Q3 2022 | -0.2% | +2.2% | +1.1% | |
| Q2 2022 | +2.5% | +1.9% | -6.0% | |
| Q1 2022 | +10.5% | +12.3% | +8.1% | |
| Q4 2021 | +4.0% | +6.2% | +12.8% | |
| Q3 2021 | +3.2% | +5.5% | +6.3% | |
| Q2 2021 | -3.5% | +3.0% | +6.9% | |
| Q1 2021 | +2.7% | -1.9% | -5.2% | |
| Q4 2020 | +1.7% | +0.1% | +3.5% | |
| Q3 2020 | +10.7% | +5.7% | -8.3% | |
| Q2 2020 | +5.8% | +8.5% | +8.2% | |
| Q1 2020 | -3.1% | -5.6% | -7.9% | |
| Q4 2019 | +3.8% | +1.1% | +0.5% | |
| Q3 2019 | -2.9% | +2.8% | -4.1% | |
| Q2 2019 | +4.3% | +12.2% | +7.4% | |
| Q1 2019 | +3.5% | +5.3% | +9.3% | |
| Q4 2018 | +25.7% | +21.4% | +25.1% | |
| Q3 2018 | -14.3% | -10.9% | -15.3% | |
| Q2 2018 | -8.3% | -9.3% | -4.9% | |
| Q1 2018 | +1.6% | +0.7% | -2.4% | |
| Q4 2017 | -8.3% | -11.2% | -9.5% | |
| Q3 2017 | +5.8% | +4.9% | +7.8% | |
| Q2 2017 | -0.5% | +0.8% | +0.6% | |
| Q1 2017 | -1.6% | -5.0% | -8.1% | |
| Q4 2016 | -0.7% | — | — | |
| Q3 2016 | +7.6% | — | — | |
| Q2 2016 | -1.7% | — | — | |
| Q1 2016 | -0.2% | — | — | |
| Q4 2015 | +3.3% | — | — | |
| Q3 2015 | +12.5% | — | — | |
| Q2 2015 | -7.6% | — | — | |
| Q1 2015 | +10.1% | — | — | |
| Q4 2014 | +0.2% | — | — | |
| Q3 2014 | -5.5% | — | — | |
| Q2 2014 | +13.2% | — | — | |
| Q1 2014 | +3.3% | — | — | |
| Q4 2013 | -0.4% | — | — | |
| Q3 2013 | +5.8% | — | — | |
| Q2 2013 | +19.9% | — | — | |
| Q1 2013 | +4.1% | — | — | |
| Q4 2010 | +1.4% | — | — | |
| Q4 2012 | +1.4% | — | — | |
| Q3 2012 | -1.0% | — | — | |
| Q3 2011 | -1.0% | — | — | |
| Q2 2011 | -4.8% | — | — | |
| Q2 2012 | -4.8% | — | — | |
| Q4 2011 | -13.0% | — | — | |
| Q1 2011 | -13.0% | — | — | |
| Q1 2012 | -13.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro